IN2013CH01516A - - Google Patents

Download PDF

Info

Publication number
IN2013CH01516A
IN2013CH01516A IN1516CH2013A IN2013CH01516A IN 2013CH01516 A IN2013CH01516 A IN 2013CH01516A IN 1516CH2013 A IN1516CH2013 A IN 1516CH2013A IN 2013CH01516 A IN2013CH01516 A IN 2013CH01516A
Authority
IN
India
Prior art keywords
curcumin
fibrinogen
thrombin
relates
delivery system
Prior art date
Application number
Other languages
English (en)
Inventor
Kalliyana Krishnan Lissy
Sreedharan Pillai Lakshmi
Original Assignee
Sree Chitra Tirunal Inst For Medical Sciences And Technology
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sree Chitra Tirunal Inst For Medical Sciences And Technology filed Critical Sree Chitra Tirunal Inst For Medical Sciences And Technology
Priority to IN1516CH2013 priority Critical patent/IN2013CH01516A/en
Priority to US14/888,185 priority patent/US10004698B2/en
Priority to PCT/IN2014/000300 priority patent/WO2014192016A1/en
Publication of IN2013CH01516A publication Critical patent/IN2013CH01516A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7007—Drug-containing films, membranes or sheets

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IN1516CH2013 2013-05-03 2014-05-05 IN2013CH01516A (cg-RX-API-DMAC7.html)

Priority Applications (3)

Application Number Priority Date Filing Date Title
IN1516CH2013 IN2013CH01516A (cg-RX-API-DMAC7.html) 2013-05-03 2014-05-05
US14/888,185 US10004698B2 (en) 2013-05-03 2014-05-05 Fibrin wafer/disc as a biological carrier for sustained delivery of curcumin
PCT/IN2014/000300 WO2014192016A1 (en) 2013-05-03 2014-05-05 Fibrin wafer/disc as a biological carrier for sustained delivery of curcumin

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1516CH2013 IN2013CH01516A (cg-RX-API-DMAC7.html) 2013-05-03 2014-05-05

Publications (1)

Publication Number Publication Date
IN2013CH01516A true IN2013CH01516A (cg-RX-API-DMAC7.html) 2015-08-07

Family

ID=51453782

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1516CH2013 IN2013CH01516A (cg-RX-API-DMAC7.html) 2013-05-03 2014-05-05

Country Status (3)

Country Link
US (1) US10004698B2 (cg-RX-API-DMAC7.html)
IN (1) IN2013CH01516A (cg-RX-API-DMAC7.html)
WO (1) WO2014192016A1 (cg-RX-API-DMAC7.html)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN187639B (cg-RX-API-DMAC7.html) 1998-02-24 2002-06-01 Sree Chitra Tirunal Inst For M
US20050208095A1 (en) * 2003-11-20 2005-09-22 Angiotech International Ag Polymer compositions and methods for their use
US20070286881A1 (en) * 2005-07-14 2007-12-13 Brian Burkinshsw Method, composition and kit for treating degenerated disc disease and discogenic pain

Also Published As

Publication number Publication date
US10004698B2 (en) 2018-06-26
WO2014192016A1 (en) 2014-12-04
US20160101066A1 (en) 2016-04-14

Similar Documents

Publication Publication Date Title
SG11201604660VA (en) Drug delivery system.
ZA201601862B (en) Mutli-chamber,multi-formulation fluid delivery system
EP3069314A4 (en) Devices, systems, and methods for automated medical product or service delivery
EA201590139A1 (ru) Шприц
EP3077653A4 (en) Multimode gas delivery for rail tender
EP2941276A4 (en) Fragrance delivery system
EP3016692A4 (en) Fragrance delivery device, system, and method
GB201313784D0 (en) Drug delivery service
UY34581A (es) Dispositivo de inhalación para fármacos en polvo
EP3302265A4 (en) Drug delivery capsule
EP3077006A4 (en) Polymer-carbohydrate conjugates for drug delivery technology
EP2968162A4 (en) Multi-stage biodegradable drug delivery platform
EP2995283A4 (en) Stent delivery system
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
MX2015008588A (es) Composiciones y metodos para la transfeccion de polinucleótidos.
MY165075A (en) Pharmaceutical composition comprising fimasartan and hydrochlorothiazide
UY34579A (es) Dispositivo de inhalación para fármacos en polvo
BR112014032501A2 (pt) composto, e, composição farmacêutica.
IL246874A0 (en) drug delivery system
EP3154524A4 (en) Extended-release drug delivery compositions
EP3217947A4 (en) Kidney-targeted drug delivery systems
UY34580A (es) Dispositivo de inhalación para fármacos en polvo
EP2996612A4 (en) Antiseptic delivery system
EP3000089A4 (en) Medication delivery management
DK2953617T3 (da) Farmaceutiske sammensætninger, der inkorporerer lavdosislægemidler